Edwards Lifesciences Corporation (EW) vs Moderna, Inc. (MRNA)

A side-by-side comparison of Edwards Lifesciences Corporation and Moderna, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of August 20, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total returnEW vs MRNA

growth of $100 · dividends reinvested · last 8y
EW +69.5% (+6.8%/yr)MRNA +837.5% (+32.3%/yr)MRNA compounded faster over this window
Log scale — wide-divergence pair
101001k10kStart $1002020202220242026$169$938
EW MRNA

EW vs MRNA: by the numbers

  • MRNA is the larger company ($69.19B vs $53.13B market cap).
  • EW is profitable (15.43% net margin) while MRNA runs a net loss (-141.43%).
  • MRNA grew revenue faster over the past five years (19.33% vs 5.75% CAGR).

Metrics side by side

Valuation

MetricEWMRNA
P/E ratio53.03N/A
Forward P/E30.75N/A
P/S ratio8.1830.99
P/B ratio5.0210.21
EV / EBITDA25.61N/A
FCF yield2.69%N/A

Profitability

MetricEWMRNA
Gross margin77.98%55.35%
Operating margin28.09%-158.13%
Net margin15.43%-141.43%
ROE9.46%-46.61%
ROIC10.22%-39.16%

Growth (annualized)

MetricEWMRNA
Revenue CAGR (5Y)5.75%19.33%
EPS CAGR (5Y)6.87%N/A
FCF CAGR (5Y)6.41%N/A
Total return CAGR (5Y)-4.79%-14.22%

Frequently asked

Which has grown faster, EW or MRNA?
Over the past five years, MRNA grew revenue faster — EW at a 5.75% CAGR versus MRNA at 19.33%.
Is EW or MRNA more profitable?
EW runs the higher net margin — EW at 15.43% versus MRNA at -141.43%.
How have EW and MRNA total returns compared?
Over the past 5 years, EW delivered 8.90% and MRNA delivered -14.22% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified August 20, 2026.